The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluating Ki67 and Oncotype DX Breast Recurrence Score during neoadjuvant treatment with letrozole/abemaciclib or chemotherapy in patients with highly proliferative HR+/HER2- breast cancer participating in the GEICAM CARABELA trial.
 
Angel Guerrero
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Novartis; Pfizer; Pierre Fabre; Seagen
Speakers' Bureau - AstraZeneca; Exact Sciences; Lilly; Novartis; Pfizer; Pierre Fabre; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Novartis; Pfizer; Pierre Fabre
 
Miguel Martin
Honoraria - Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; SEAGEN
Consulting or Advisory Role - AstraZeneca; Daiichi-Sankyo; Lilly; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - Lilly/ImClone; Lilly/ImClone; Pierre Fabre; Roche/Genentech
Research Funding - Novartis (Inst); Puma Biotechnology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Daichii-Sankyo
Other Relationship - Novartis; Roche
 
Maria Eva Perez
Speakers' Bureau - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Manuel Ruiz-Borrego
Honoraria - Novartis; pfizer; Roche/Genentech
Consulting or Advisory Role - Puma Biotechnology; Roche
 
Noelia Martinez-Jañez
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche
Research Funding - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Jose Ignacio Chacon
Consulting or Advisory Role - AstraZeneca Spain; Daiichi Sankyo/Astra Zeneca; Eisai; Lilly; Merck; Novartis; Pfizer; Roche
 
Miguel J. Gil Gil
Honoraria - AstraZeneca; Daiichi-Sankyo; Pfizer
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Seagen
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche
 
Raquel Andrés
Consulting or Advisory Role - Lilly; seagen
Speakers' Bureau - daichi; Lilly; Novartis; Pfizer; Pierre Fabre
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca; Pierre Fabre
 
Pedro Sanchez-Rovira
No Relationships to Disclose
 
Sonia Del Barco
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo
Speakers' Bureau - Gilead Sciences; Lilly; Novartis
 
Begoña Bermejo
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; MSD; Novartis; Pfizer
Speakers' Bureau - Daiichi Sankyo; Gilead Sciences; Lilly; Novartis
Travel, Accommodations, Expenses - AstraZeneca; Pfizer
 
Isaura Fernández
Consulting or Advisory Role - Seagen
Travel, Accommodations, Expenses - GlaxoSmithKline/MSD
 
Elisa García
Travel, Accommodations, Expenses - Roche
Other Relationship - Lilly; Novartis
 
Blanca Hernando
Travel, Accommodations, Expenses - Lilly
 
Juan De La Haba
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Novartis; Roche
 
Jesús Herranz
No Relationships to Disclose
 
Marta Portela
No Relationships to Disclose
 
Rosalia Caballero
No Relationships to Disclose
 
Federico Gustavo Rojo Todo
Consulting or Advisory Role - AstraZeneca; BMS GmbH & Co. KG; GlaxoSmithKline; Lilly; Menarini; Merck; MSD; Roche
Speakers' Bureau - AstraZeneca; Menarini
 
Emilio Alba Conejo
Consulting or Advisory Role - BMS GmbH & Co. KG; Exact Sciences; Lilly; Novartis; Pfizer; Roche